Authors


Sawsan Khan, MD

Latest:

“I’m Not Ready to Die”

A patient, faced with a lung cancer diagnosis and the fear of death, goes through the stages of grief. How can you as clinicians lead them through?


Erin Cassidy-Eagle, PhD, DBSM

Latest:

Recognizing and Addressing Psychiatric Implications of Sleep Disorders

What sleep disorders are common in older adults and what are the associated risk factors and correlates?


Joshua Friedman, MD, PhD

Latest:

Insights From the 2022 AAPL Annual Meeting

The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.



David Auer, CPA, MS, PFS, CGMA

Latest:

Planning for Your 2022 Taxes

Let's plan for your 2022 taxes.


Anu Bodla, MD

Latest:

How Psychiatrists Can Guide Distance Learning

Children with autism spectrum disorder have special educational needs, but with proper guidance they can flourish, even during a pandemic.


Carmen R. Green, MD

Latest:

Racism, Policing, and COVID-19 Disparities: We Need Action!

This moment in history cannot be lost. When you ask us if we are okay, be prepared to hear us say we are not . . . and never have been. Then be prepared to do more.


Shekhar Saxena, MD

Latest:

Telling Humanity’s Brain Story: Insights From Brain Capital

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?


Natalie Ceballos, PhD

Latest:

Social Media and Substance Use: What Clinicians Need to Know

Social media is here to stay, and its use must be a consideration in the treatment of psychiatric conditions, particularly substance use disorder and alcohol use disorder.


The PRO Group (Psychiatric Reparations Opportunities)

Latest:

The Case for Psychiatric Reparations

A diverse group of psychiatrists elaborates on the difficult conversation surrounding reparations, and why our society needs to pay attention.


Michael Parish, MD

Latest:

Easy To Miss, Hard to Treat: Notes on Frontotemporal Dementia

Often misdiagnosed as other psychiatric disorders, FTD is the third most common type of dementia and the second most common among patients 65 years or younger. How to spot the signs.


Lauren Zuchman

Latest:

Community Involvement Can Enhance Mental Health

“I have found that community involvement is really key to a sense of belonging and really feeding our soul as we think about maintaining our mental health.”


Shelby Arnold, PhD

Latest:

Recovery-Oriented Cognitive Therapy: A Game Changer for Justice-Involved Individuals

"CT-R emphasizes the importance of hope while taking it a step further, turning hope into meaningful action and internalizing what success says about a person’s identity, strength, and ability to navigate future challenges."


Karen Appold

Latest:

Health Care Trends Expected in 2022

What trends might be expected for health care in 2022?


Lara Segalite, MD

Latest:

Telepsychiatry in the Setting of COVID-19 and Beyond

What are the challenges and opportunities for improvement in COVID-19-related mental health care?


Craig Chepke, MD, DFAPA, FAPA

Latest:

Final Pearls: Changing Possibilities in MDD Management

Clinicians wrap up their discussion on novel, rapid-acting agents for major depressive disorder (MDD) with key insights and takeaways for providers.



Joshua C. Briscoe, MD

Latest:

Affirming Dignity: Arguments Against Medical Aid in Dying

Instead of figuring out ways to help people die, what if we devoted our energy to helping them live, even and especially if they are dying?


Prashanth Puspanathan, MD

Latest:

Challenging the Status Quo of the Challenge to the Status Quo

How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?


Scott Kaiser, MD

Latest:

Anthropology-Informed Business Principles for Brain Health

The key to addressing mental health may lie in business innovation theories.


Jim Gilligan, PhD, MBIS

Latest:

The Gut-Brain Connection: An Upcoming Study on Psilocybin-Assisted Psychotherapy and Irritable Bowel Syndrome

A phase 2A trial recently received confirmation to proceed in investigating psilocybin-assisted psychotherapy in the treatment of adult patients with IBS.


Mohan Nair, MD

Latest:

Ketamine and Psychedelics: The Journey From Magical Mystery to Informed Consent

In this CME article, learn more about the best practices for engaging patients in the informed consent process for psychedelic treatment and psychedelic-assisted psychotherapy.


Frank Chen, MD

Latest:

Long-Acting Injectable Antipsychotics in the Era of COVID-19

COVID-19 has made treating patients who receive long-acting injectables complicated. The Chief Medical Officer of Houston Behavioral Healthcare Hospital offers suggestions on how best to proceed.


Marco Mula, MD, PhD, FRCP, FEAN

Latest:

Psychiatric Comorbidities in Epilepsy: Implications for Clinical Practice

Psychiatric disorders affect 1 in 3 individuals with epilepsy—and their etiology is multifactorial.


Mona Mojtahedzadeh, MD

Latest:

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.


Maha N. Mian, PhD

Latest:

Addressing Alcohol or Cannabis Use in Patients With Anxiety Disorders

In this CME article, learn more about how to assess the impact of alcohol and cannabis use on anxiety treatment outcomes, recognizing potential adverse effects and interactions.


Jeremy Barnett, LMHC, CASAC

Latest:

Keeping the Holiday Spirit (Without the Holiday Spirits)

Tips for helping patients preserve their sobriety through the holiday season


David Seigler, MD, FAPA

Latest:

Reentry Anxiety

Why does the prospect of getting back to normal after the pandemic disturb some patients? And what can be done to overcome these fears?


Nick Rushworth

Latest:

Violence Against Women and Acquired Brain Injuries

Violence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.


Donald E. McLawhorn, Jr, MD, PhD

Latest:

Trauma and Transition Trajectories: The Risk of Caenisian Reversion

How can you best address and support transgender patients, as well as prevent negative outcomes?

© 2024 MJH Life Sciences

All rights reserved.